We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

134 hedge funds and large institutions have $315M invested in Cytokinetics in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 21

2% more funds holding

Funds holding: 132 → 134 (+2)

7% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 46

2.32% less ownership

Funds ownership: 73.92% → 71.59% (-2.3%)

38% less call options, than puts

Call options by funds: $1.24M | Put options by funds: $1.99M

45% less capital invested

Capital invested by funds: $575M → $315M (-$261M)

Holders
134
Holders Change
+2
Holders Change %
+1.52%
% of All Funds
3.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
43
Reduced
46
Closed
21
Calls
$1.24M
Puts
$1.99M
Net Calls
-$754K
Net Calls Change
-$3.51M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$50.9M
2
WA
Wasatch Advisors
Utah
+$11.1M
3
State Street
State Street
Massachusetts
+$10M
4
BlackRock
BlackRock
New York
+$4.47M
5
TCM
Tekla Capital Management
Massachusetts
+$3.98M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$40.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$24.7M
3
Citadel Advisors
Citadel Advisors
Florida
-$9.4M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$9.33M
5
Invesco
Invesco
Georgia
-$7.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
TRSOTSOK
101
Teachers Retirement System of the State of Kentucky
Kentucky
$87K – – –
FGC
102
Financial Gravity Companies
Texas
$86K +$106K +9,302 New
PIA
103
Piedmont Investment Advisors
North Carolina
$85K -$6.56K -578 -5%
BC
104
Birchview Capital
Vermont
$82K – – –
SOADOR
105
State of Alaska Department of Revenue
Alaska
$82K – – –
Parallax Volatility Advisers
106
Parallax Volatility Advisers
California
$52K +$72K +6,342 New
PNC Financial Services Group
107
PNC Financial Services Group
Pennsylvania
$41K -$12.9K -1,137 -18%
TRCT
108
Tower Research Capital (TRC)
New York
$41K +$37.8K +3,327 +196%
Simplex Trading
109
Simplex Trading
Illinois
$36K -$14.2K -1,253 -22%
CG
110
Cutler Group
California
$33K -$69K -6,081 -60%
LTFS
111
Ladenburg Thalmann Financial Services
Florida
$32K +$261 +23 +0.6%
AIP
112
Ameritas Investment Partners
Nebraska
$30K – – –
QT
113
Quantbot Technologies
New York
$21K +$29.3K +2,577 New
Federated Hermes
114
Federated Hermes
Pennsylvania
$17K +$17.9K +1,580 +327%
STA
115
Summit Trail Advisors
New York
$16K +$19.1K +1,680 New
Zurich Cantonal Bank
116
Zurich Cantonal Bank
Switzerland
$15K +$20.8K +1,832 New
LIA
117
LS Investment Advisors
Michigan
$12K -$105K -9,266 -86%
Pacer Advisors
118
Pacer Advisors
Pennsylvania
$10K +$14.2K +1,250 New
Bank of Montreal
119
Bank of Montreal
Ontario, Canada
$8K -$1.08M -95,437 -99%
GWM
120
Geneos Wealth Management
Colorado
$8K – – –
IWM
121
IHT Wealth Management
Illinois
$7K +$9.08K +800 New
Macquarie Group
122
Macquarie Group
Australia
$7K +$10.2K +900 New
Royal Bank of Canada
123
Royal Bank of Canada
Ontario, Canada
$6K -$186K -16,417 -96%
LWM
124
Lenox Wealth Management
Ohio
$5K – – –
MAM
125
Meeder Asset Management
Ohio
$4K +$602 +53 +12%
3 4
5
6 7

CYTK Hedge Fund Activity: Q4 2017 in Review

134 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2017, worth a combined $315M — down 45% from $575M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new CYTK positions and 21 closed out — a net gain of 3 holders — while 43 added to existing stakes and 46 trimmed.

The largest buyer was BVF Inc, adding an estimated $50.9M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $40.3M sold.

  • 134 institutional investors held Cytokinetics (CYTK) as of Q4 2017, up from 132 in Q3 2017.
  • Funds reported $315M of Cytokinetics stock for Q4 2017, down 45% quarter-over-quarter.
  • 24 funds opened new Cytokinetics positions in Q4 2017 and 21 closed out, a net change of +3 holders.
  • The largest Cytokinetics buyer in Q4 2017 was BVF Inc, an estimated $50.9M added.
  • The largest Cytokinetics seller in Q4 2017 was Janus Henderson Group, an estimated $40.3M sold.

Based on aggregated 13F filings for Q4 2017.